Epstein Secrets

).5; Lyme Ab/Western Blot Reflex Iron and TIBC; Testosterone,Pree+weakly Bound; Prolactin; OHM-Sulfate; Homocystle)ine. Plasma; C-Reactive Protein, Cardiac: Hemoglobin Ale: Prostate-Specific Ag. Serum TSH; Vitamin D, 25-Hydroxy; Uric Acid, Serum; GOT; Insulin; Ambiguous Test Order; Ferritin, Serum Requ

tes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.8 ng/mL 4.8 - 5.6 02 0.0 - 4.0 02 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

for CHD. HDL-C >59 mg/dL is considered a 79 High mg/dL 5 - 40 116 High mg/dL 0 - 99 3.7 High ratio units 0.0 - 3.6 C-Reactive Protein, Cardiac 0.79 Relative Risk for 01 01 01 01 01 01 01 01 01 01 01 01 mg/L 0.00 - 3.00 01 Future Cardiovascular Event Low <1.00 Average Hi

result with this method. Prostate—Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

, is considered to represent clinical deficiency. FSH and LH LH 3.7 mIU/mL 1.7 - 8.6 01 FSH 4.4 miU/mL 1.5 - 12.4 01 C-Reactive Protein, Cardiac 1.56 mg/L 0.00 - 3.00 01 Relative Risk for Future Cardiovascular Event Low <1.00 Average 1.00 - 3.00 High >3.00 Hemoglobin Ale Hemoglobi

ults with diabetes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

ulfate; Cortisol; TSH; Rheumatoid Arthritis Factor; Prostate -Specific Ag, Serum; IGF-1; Vitamin D, 25-Hydroxy; Panel 083935; C-Reactive Protein, Cardiac; HCV Ab w/Rflx to Verification; ANA w/Reflex; Homocyst(e)ine, Plasma; Uric Acid, Serum; LDH; GGT; Magnesium, Serum; Zinc, Plasma or serum; Insulin;

ITS REFERENCE INTERVAL LAB Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.6 ng/mL 0.0 - 4.0 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

, Routine; PE+Interp(Rfx IFE),S; Lipid Panel; Iron and TIBC; Testosterone,Free+Weakly Bound; Vitamin 812 and Folate; FSH and Lit C-Reactive Protein, Cardiac; Hemoglobin Ale: Prostate-Specific Ag. Serum; TSH; Vitamin D. 26-Hydroxy; Lipoprotein (a); IGF-1; ANA vt/Reflex; Homocyst(e)ine, Plasma; ProlaCtini

257-S80-2371D Date collected:09/14/2018 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB TSH Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

Note: A serum folate concentration of less than 3.1 ng/mL is considered to represent clinical deficiency. FSH and LH LH FSH C-Reactive Protein, Cardiac 463 4.4 pg/mL ng/mL 232 - 1245 >3.0 01 01 01 3.7 mIU/mL 1.7 - 8.6 01 4.4 mIU/mL 1.5 - 12.4 01 1.56 mg/L 0.00 - 3.00 01 Relative

with diabetes: <7.0 01 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA